Protagonist Therapeutics, Inc — Director's Dealing 2017

Jun 16, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Protagonist Therapeutics, Inc (PTGX)
CIK: 0001377121
Period of Report: 2017-06-15

Reporting Person: Williams Lewis T (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-06-15	Stock Option (right to buy)	$10.84	A	24000	Acquired	2027-06-15	Common Stock (24000)	Direct

Footnotes

F1: The shares subject to the option shall vest in 36 equal monthly installments from the vesting commencement date of June 15, 2017.